Lake Street Advisors Group’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Lake Street Advisors Group’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,206	Closed	-$29.1K	–	666
2024 Q2	$29.1K	Hold	21,206	–	–	﹤0.01%	611
2024 Q1	$55.7K	Hold	21,206	–	–	﹤0.01%	608
2023 Q4	$76.6K	Hold	21,206	–	–	﹤0.01%	575
2023 Q3	$222K	Hold	21,206	–	–	0.01%	239
2023 Q2	$234K	Sell	21,206 -3,432	-14%	-$35.2K	0.01%	234
2023 Q1	$291K	Hold	24,638	–	–	0.02%	216
2022 Q4	$355K	Hold	24,638	–	–	0.02%	209
2022 Q3	$1.23M	Hold	24,638	–	–	0.09%	137
2022 Q2	$2.1M	Hold	24,638	–	–	0.15%	96
2022 Q1	$3.72M	Hold	24,638	–	–	0.24%	63
2021 Q4	$7.37M	Buy	24,638 +3,431	+16%	+$1.32M	0.46%	37
2021 Q3	$8.27M	Buy	+21,207	New	+$9.04M	0.89%	26

Lake Street Advisors Group's FNCH Position: Q3 2024 in Review

Lake Street Advisors Group sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q3 2024, closing a stake of 21,206 shares — an estimated $29.1K sold.

Lake Street Advisors Group first reported a position in FNCH in Q3 2021 and held it in 12 quarters. The position peaked at $8.27M in Q3 2021. 0 funds tracked by Wall St. Rank hold FNCH as of Q3 2024.

Lake Street Advisors Group reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Lake Street Advisors Group sold 21,206 Finch Therapeutics Group, Inc. Common Stock shares in Q3 2024, an estimated $29.1K.
Lake Street Advisors Group first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q3 2021 and held it in 12 quarters.
Lake Street Advisors Group's Finch Therapeutics Group, Inc. Common Stock position peaked at $8.27M in Q3 2021.
0 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q3 2024.

Based on Lake Street Advisors Group's 13F filing for Q3 2024, filed 23 Oct 2024.